BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 15658878)

  • 21. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
    Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM
    J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.
    Saczewski F; Reszka P; Gdaniec M; Grünert R; Bednarski PJ
    J Med Chem; 2004 Jun; 47(13):3438-49. PubMed ID: 15189040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
    Leese MP; Jourdan FL; Gaukroger K; Mahon MF; Newman SP; Foster PA; Stengel C; Regis-Lydi S; Ferrandis E; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2008 Mar; 51(5):1295-308. PubMed ID: 18260615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
    J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
    Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
    Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives.
    Li HH; Zheng XH; Tan JZ; Chen LL; Liu H; Luo XM; Shen X; Lin LP; Chen KX; Ding J; Jiang HL
    Acta Pharmacol Sin; 2007 Jan; 28(1):140-52. PubMed ID: 17184594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
    Leese MP; Hejaz HA; Mahon MF; Newman SP; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2005 Aug; 48(16):5243-56. PubMed ID: 16078843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.
    Llauger L; He H; Kim J; Aguirre J; Rosen N; Peters U; Davies P; Chiosis G
    J Med Chem; 2005 Apr; 48(8):2892-905. PubMed ID: 15828828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
    Dong XC; Zhou FS; Zheng JB; Wen R
    Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
    Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P
    Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
    Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
    Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
    Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
    J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of 6H-isoindolo[2,1-a]indol-6-ones, analogues of batracylin, and related compounds.
    Guillaumel J; Léonce S; Pierré A; Renard P; Pfeiffer B; Arimondo PB; Monneret C
    Eur J Med Chem; 2006 Mar; 41(3):379-86. PubMed ID: 16442188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives.
    El-Sawy ER; Bassyouni FA; Abu-Bakr SH; Rady HM; Abdlla MM
    Acta Pharm; 2010 Mar; 60(1):55-71. PubMed ID: 20228041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents.
    Reddy MV; Mallireddigari MR; Cosenza SC; Pallela VR; Iqbal NM; Robell KA; Kang AD; Reddy EP
    J Med Chem; 2008 Jan; 51(1):86-100. PubMed ID: 18088089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Welsh W; Arora S; Farruggia G; Masotti L
    J Med Chem; 2005 Aug; 48(17):5604-7. PubMed ID: 16107161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
    Yarim M; Koksal M; Schepmann D; Wünsch B
    Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.